We are live on
!
Find out more
VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$160M
1-Year Est. Return
517.12%
This Fund
S&P 500
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$16.3M
(+15%)
Cap. Flow
+$33.6M
Cap. Flow
% of AUM
27.07%
Top 10 Holdings %
Top 10 Hldgs %
77.75%
Holding
36
New
5
Increased
4
Reduced
4
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALIM
Alimera Sciences
ALIM
|
+$39.5M |
| 2 |
Inspire Medical Systems
INSP
|
+$3.86M |
| 3 |
Heron Therapeutics
HRTX
|
+$3.54M |
| 4 |
Gossamer Bio
GOSS
|
+$3.53M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADMA Biologics
ADMA
|
+$3.81M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
+$3.12M |
| 3 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
+$3.11M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$2.17M |
| 5 |
Tenet Healthcare
THC
|
+$2.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rezolute
RZLT
$453M
| $528K | 0.43% |
400,000
| – | – |
|
|
QIPT
27
CALL
DELISTED
Quipt Home Medical
QIPT
| $509K | 0.41% |
100,000
| – | – |
|
|
INBX
28
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $459K | 0.37% |
25,000
| – | – |
|
|
ELEV
29
DELISTED
Elevation Oncology
ELEV
| $330K | 0.27% |
497,299
| – | – |
|
30
CALL
AirSculpt Technologies
AIRS
$234M
| – | – |
-75,000
| Closed | -$647K |
|
|
AVDL
31
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-100,000
| Closed | -$1.65M |
|
|
ETNB
32
DELISTED
89bio
ETNB
| – | – |
-95,000
| Closed | -$1.8M |
|
33
Iovance Biotherapeutics
IOVA
$3.05B
| – | – |
-240,000
| Closed | -$1.57M |
|
|
CTLT
34
DELISTED
CATALENT, INC.
CTLT
| – | – |
-50,000
| Closed | -$2.17M |
|
|
GRTX
35
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| – | – |
-1,000,000
| Closed | -$3.12M |
|
|
PNT
36
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-342,936
| Closed | -$3.11M |
|
Similar funds
BFAG
SLG
SMF
LCA
SGCM
RP
PCC
RCWM
Velan Capital Investment Management's Q3 2023 Portfolio in Review
As of Q3 2023, Velan Capital Investment Management held 36 positions worth $124M, up 15% from $108M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Velan Capital Investment Management deployed $33.6M of net new capital in Q3 2023, opening 5 new positions and adding to 4 existing holdings. Its largest new stake was Inspire Medical Systems: 15,300 shares worth $3.04M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier.
On the sell side, the largest reduction was ADMA Biologics, an estimated $3.81M trimmed.
- Velan Capital Investment Management's largest Q3 2023 buy was Inspire Medical Systems: 15,300 shares worth $3.04M.
- Velan Capital Investment Management added most to Alimera Sciences in Q3 2023, an estimated $39.5M increase.
- Velan Capital Investment Management's biggest Q3 2023 reduction was ADMA Biologics, cutting an estimated $3.81M.
- Velan Capital Investment Management fully exited Galera Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $3.12M.
- Velan Capital Investment Management's ten largest holdings make up 78% of its $124M portfolio in Q3 2023.
- Velan Capital Investment Management opened 5 new positions and closed 7 in Q3 2023.
- Velan Capital Investment Management's portfolio value rose 15% quarter-over-quarter to $124M.
Based on Velan Capital Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.